Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600–Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials

IMPORTANCE: Prognostic models may provide insight into clinical trial results and inform the clinical management of patients with BRAF V600–mutated metastatic melanoma. OBJECTIVE: To identify subgroups with distinct survival outcomes based on clinical and genomic characteristics and to assess surviv...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA Oncol
Prif Awduron: Hauschild, Axel, Larkin, James, Ribas, Antoni, Dréno, Brigitte, Flaherty, Keith T., Ascierto, Paolo A., Lewis, Karl D., McKenna, Edward, Zhu, Qian, Mun, Yong, McArthur, Grant A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2018
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233771/
https://ncbi.nlm.nih.gov/pubmed/30073321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.2668
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg